Chad Cowan, Clade Therapeutics CEO

CRISPR Ther­a­peu­tics co-founder un­cloaks an off-the-shelf cell ther­a­py start­up with $87M and a lot of fan­fare

When Chad Cow­an was re­cruit­ed to Har­vard Uni­ver­si­ty 20 years ago to work on hu­man em­bry­on­ic stem cells, he was in­spired by the idea that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA